Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Francisco Kerr Saraiva
Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Related publications
Glucagon-Like Peptide-1 Receptor (GLP1R; GLP-1R)
Science-Business eXchange
Pdb12 - Cardiovascular Safety of Empagliflozin Versus Glucagon-Like Peptide-1 (Glp-1) Receptor Agonists: Systematic Literature Review and Indirect Comparisons
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Cardiovascular Effects of GLP-1 Receptor Agonists
Cardiovascular Therapeutics
Medicine
Cardiovascular Medicine
Pharmacology
Cardiology
Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Synthesis and Biological Evaluation of Glucagon-Like Peptide-1 Receptor Agonists
Archives of Pharmacal Research
Organic Chemistry
Drug Discovery
Molecular Medicine
Cardiovascular and Hemodynamic Effects of Glucagon-Like Peptide-1
Reviews in Endocrine and Metabolic Disorders
Endocrinology
Metabolism
Diabetes
Glucagon-Like Peptide-1 Receptor (GLP-1R) Signaling Ameliorates Dysfunctional Immunity in COPD Patients
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
Effects of Subcutaneous Glucagon-Like Peptide 1 (GLP-1 [7-36 Amide]) in Patients With NIDDM
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Equine Glucagon-Like Peptide-1 Receptor Physiology
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
